Tucker; Thomas J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Tucker; Thomas J..The latest application filed is for "dual molecular delivery of oligonucleotides and peptide containing conjugates".
- Tucker; Thomas J. - North Wales PA
- Tucker, Thomas J - North Wales PA
| Patent | Date |
|---|---|
| Dual molecular delivery of oligonucleotides and peptide containing conjugates Grant 10,532,068 - Colletti , et al. Ja | 2020-01-14 |
| Peptide containing conjugates for dual molecular delivery of oligonucleotides Grant 10,239,957 - Colletti , et al. | 2019-03-26 |
| Dual Molecular Delivery Of Oligonucleotides And Peptide Containing Conjugates App 20190015442 - Colletti; Steven L. ; et al. | 2019-01-17 |
| Dual molecular delivery of oligonucleotides and peptide containing conjugates Grant 10,010,562 - Colletti , et al. July 3, 2 | 2018-07-03 |
| Dual Molecular Delivery Of Oligonucleotides And Peptide Containing Conjugates App 20170189441 - Colletti; Steven L. ; et al. | 2017-07-06 |
| Novel Single Chemical Entities And Methods For Delivery Of Oligonucleotides App 20170137815 - COLLETTI; Steven L. ; et al. | 2017-05-18 |
| Peptide Containing Conjugates For Dual Molecular Delivery Of Oligonucleotides App 20170081425 - Colletti; Steven L. ; et al. | 2017-03-23 |
| Novel Single Chemical Entities And Methods For Delivery Of Oligonucleotides App 20160074525 - COLLETTI; Steven L. ; et al. | 2016-03-17 |
| Single chemical entities and methods for delivery of oligonucleotides Grant 8,691,580 - Aaronson , et al. April 8, 2 | 2014-04-08 |
| Novel Single Chemical Entities And Methods For Delivery Of Oligonucleotides App 20130253168 - Colletti; Steven L. ; et al. | 2013-09-26 |
| Caprolactam Mglur5 Receptor Modulators App 20130203735 - Sisko; John T. ; et al. | 2013-08-08 |
| Non-nucleoside reverse transcriptase inhibitors Grant 8,404,856 - Tucker , et al. March 26, 2 | 2013-03-26 |
| Novel Single Chemical Entities And Methods For Delivery Of Oligonucleotides App 20130041133 - Aaronson; Jeffrey G. ; et al. | 2013-02-14 |
| CGRP receptor antagonists Grant 7,994,325 - Paone , et al. August 9, 2 | 2011-08-09 |
| Non-nucleoside Reverse Transcriptase Inhibitors App 20100256181 - Tucker; Thomas J. ; et al. | 2010-10-07 |
| HIV reverse transcriptase inhibitors Grant 7,807,684 - Saggar , et al. October 5, 2 | 2010-10-05 |
| Cgrp Receptor Antagonists App 20080261972 - Paone; Daniel V. ; et al. | 2008-10-23 |
| Carboxamide spirolactam CGRP receptor antagonists Grant 7,390,798 - Williams , et al. June 24, 2 | 2008-06-24 |
| Carboxamide Spirolactam Cgrp Receptor Antagonists App 20070293470 - Williams; Theresa M. ; et al. | 2007-12-20 |
| Tyrosine kinase inhibitors Grant 7,265,134 - Hartman , et al. September 4, 2 | 2007-09-04 |
| HIV reverse transcriptase inhibitors App 20070021442 - Saggar; Sandeep A. ; et al. | 2007-01-25 |
| Tyrosine kinase inhibitors Grant 7,115,597 - Bilodeau , et al. October 3, 2 | 2006-10-03 |
| Tyrosine kinase inhibitors App 20040242637 - Hartman, George D ; et al. | 2004-12-02 |
| Tyrosine kinase inhibitors App 20040192926 - Hartman, George D. ; et al. | 2004-09-30 |
| Tyrosine kinase inhibitors App 20040063720 - Bilodeau, Mark T. ; et al. | 2004-04-01 |
| Tyrosine kinase inhibitors App 20020137755 - Bilodeau, Mark T. ; et al. | 2002-09-26 |
| Thrombin inhibitors Grant 5,798,377 - Lumma , et al. August 25, 1 | 1998-08-25 |
| Pyridinone thrombin inhibitors Grant 5,792,779 - Sanderson , et al. August 11, 1 | 1998-08-11 |
| Piperidine and hexahydropyridazine thrombin inhibitors Grant 5,714,485 - Lumma , et al. February 3, 1 | 1998-02-03 |
| Thrombin inhibitors Grant 5,629,324 - Vacca , et al. May 13, 1 | 1997-05-13 |
| Pyrrolidine thrombin inhibitors Grant 5,510,369 - Lumma , et al. April 23, 1 | 1996-04-23 |
| Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses Grant 4,666,913 - Kubla , et al. May 19, 1 | 1987-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 